FDAnews
www.fdanews.com/articles/73821-ciphergen-to-collaborate-with-bayer

CIPHERGEN TO COLLABORATE WITH BAYER

June 28, 2005

Ciphergen Biosystems has announced that it has agreed to collaborate with Bayer Pharmaceuticals to develop a test for possible use in a Bayer clinical trial. Using its proprietary technology, Ciphergen said it will analyze patient samples from Phase II trials, identify biomarkers that could predict response to an experimental Bayer compound. The test could be used for a possible cancer study, Ciphergen said. Financial terms were not disclosed, but the company said the agreement includes upfront fees and milestone payments.

Forbes (http://www.forbes.com/associatedpress/feeds/ap/2005/06/27/ap2112938.html)